ArticleOncotarget2017

EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.

Tongle Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.